Indeed, a significant relationship between the pathogenesis of AAA and serum IL-1β and CCL5 levels has been reported, indicating that aortic aneurysm formation and progression could be blocked by genetic or pharmacological inhibition of IL-1β or CCL5 [22, 23]. This evidence concerns the gene IL1B and triple-A syndrome.